Business Description
Prestige Biologics Co Ltd
ISIN : KR7334970001
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.26 | |||||
Equity-to-Asset | 0.3 | |||||
Debt-to-Equity | 1.79 | |||||
Debt-to-EBITDA | -45.17 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -0.39 | |||||
Beneish M-Score | -0.77 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -62.7 | |||||
3-Year EBITDA Growth Rate | -13.6 | |||||
3-Year EPS without NRI Growth Rate | -27.8 | |||||
3-Year FCF Growth Rate | -52.2 | |||||
3-Year Book Growth Rate | 28.5 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 68.53 | |||||
9-Day RSI | 58.17 | |||||
14-Day RSI | 51.04 | |||||
6-1 Month Momentum % | -18.77 | |||||
12-1 Month Momentum % | -4.53 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.75 | |||||
Quick Ratio | 0.66 | |||||
Cash Ratio | 0.48 | |||||
Days Inventory | 2414.33 | |||||
Days Sales Outstanding | 16.12 | |||||
Days Payable | 315.27 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -24.3 | |||||
Shareholder Yield % | -3 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 16.05 | |||||
Operating Margin % | -1850.81 | |||||
Net Margin % | -1037.87 | |||||
FCF Margin % | -650.11 | |||||
ROE % | -17.53 | |||||
ROA % | -5.99 | |||||
ROIC % | -11.02 | |||||
ROC (Joel Greenblatt) % | -4.51 | |||||
ROCE % | -4.43 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 148.76 | |||||
PB Ratio | 2.82 | |||||
Price-to-Tangible-Book | 2.85 | |||||
Price-to-Operating-Cash-Flow | 230.55 | |||||
EV-to-EBIT | -36.16 | |||||
EV-to-EBITDA | -104.74 | |||||
EV-to-Revenue | 221.02 | |||||
EV-to-FCF | -34.08 | |||||
Earnings Yield (Greenblatt) % | -2.77 | |||||
FCF Yield % | -4.33 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Prestige Biologics Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 1,718.839 | ||
EPS (TTM) (â‚©) | -336 | ||
Beta | 1.15 | ||
Volatility % | 18.81 | ||
14-Day RSI | 51.04 | ||
14-Day ATR (â‚©) | 138.222747 | ||
20-Day SMA (â‚©) | 4150.25 | ||
12-1 Month Momentum % | -4.53 | ||
52-Week Range (â‚©) | 3850 - 5550 | ||
Shares Outstanding (Mil) | 61.24 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Prestige Biologics Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Prestige Biologics Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Prestige Biologics Co Ltd Frequently Asked Questions
What is Prestige Biologics Co Ltd(XKRX:334970)'s stock price today?
When is next earnings date of Prestige Biologics Co Ltd(XKRX:334970)?
Does Prestige Biologics Co Ltd(XKRX:334970) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |